Loading clinical trials...

CVD/PH and Voice Characteristics | Clinical Trials | Clareo Health

RECRUITING

CVD/PH and Voice Characteristics

Cardiovascular Disease/ Pulmonary Hypertension and Voice Characteristics Study

NCT07311044•Mayo Clinic

Summary

The purpose of this study is to determine the association between patient voice signal characteristics and the presence and severity of pulmonary hypertension in patients referred for elective clinically indicated echocardiography for at Mayo Clinic MN.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•All individuals who present for a routine elective, clinically indicated, diagnostic echocardiogram at the echocardiography laboratory at Mayo Clinic
•All individuals who have had a clinically indicated, diagnostic echocardiogram at the echocardiography lab at Mayo Clinic before a scheduled procedure in the cardiac catheterization lab at Mayo Clinic
•All individuals who have had a clinically indicated diagnostic echocardiogram at the echocardiography lab at Mayo Clinic and have an appointment in any CV outpatient clinic.

Exclusion Criteria

•Known history of voice disorder either primary or secondary to neuromuscular or other pathology
•Patients under the age of 18 years

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States

Key Dates

Start Date

January 8, 2021

Primary Completion Date

January 1, 2027

Completion Date

January 1, 2027

Last Updated

December 30, 2025

Enrollment

7,000

ESTIMATED participants

Conditions

Pulmonary HypertensionCardiovascular Diseases

Contacts

Diana Albers

CONTACT

507-255-6884 albers.diana2@mayo.edu

Amir Lerman, M.D.

CONTACT

lerman.amir@mayo.edu

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820

Pulmonary Hypertension

View study

RECRUITINGNA

The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases

NCT06909773

Cardiovascular Diseases

View study

RECRUITINGNA

OPTImizing CArdiac REhabilitation by REfining Sleep and STress

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 30, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

CVD/PH and Voice Characteristics

Inclusion Criteria

Exclusion Criteria

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases

OPTImizing CArdiac REhabilitation by REfining Sleep and STress

CLEANer Aspiration for Pulmonary Embolism

Preliminary Human Trials of F230 Tablets

The CACHE Study: Coronary Artery Care in HaEmophilia